How to benefit from an NCVD Registry: The NCVD Experience from Malaysia 15th Vietnam Congress of Cardiology, National Convention Centre, Hanoi, 9-11 October 2016; Dr Alan Fong MBChBB
Trang 1How to benefit from an NCVD Registry:
The NCVD Experience from Malaysia
15th Vietnam Congress of Cardiology, National Convention Centre,
Hanoi, 9-11 October 2016;
Dr Alan Fong
MBChB(Bristol), MRCP(UK), FRCP (Edin), FACC, FESC, FAPSIC, FNHAM, FAsCC
Consultant Cardiologist, Sarawak General Hospital Heart Centre;
& Head, Clinical Research Centre, Sarawak General Hospital
Trang 2Background
Trang 3Where we are…
Trang 4Sarawak Heart Centre
H
H♥
Trang 5National Health and Morbidity Surveys (e.1986)
Trang 6The NCVD Registries (e.2006)
http://www.acrm.org.my/ncvd/aboutUs_overview.php
Trang 7NCVD PCI Registry Report 2013-2014
Trang 8Snapshot from the
Annual Report of the NCVD-ACS Registry
2011-2013
Suggested citation:
W.A Wan Azman, K.H Sim (Eds) Annual Report of the NCVD-ACS Registry, Year 2011-2013 Kuala Lumpur, Malaysia: National Cardiovascular Disease Database, 2015
Trang 9NCVD-ACS Registry Participating
Total SDP= 19 hospitals
*Each SDP started to contribute data at different
time period
HSNZ
Trang 10N ACS admissions = 14,763
Trang 11Mean age: 58.5 (12.2) years
N ACS admissions = 14,763
Trang 12N ACS admissions = 14,763
Trang 13CV Risk factors 2006- 2010
(N=16,866)
2011 (N=4,047) 2012
(N=4,589) 2013
(N=6,127)
2011-2013 (N=14,763)
(onset > 2 weeks ago) 11.0 11.4 9.6 9.4 9.9
Trang 14Presence of cumulative risk factors (Percentage),
NCVD-ACS Registry, 2011-2013
Trang 16Type of cardiac presentation for patients with ACS (%)
by admission, NCVD-ACS Registry, 2006 - 2013
2006 2007 2008 2009 2010 2011 2012 2013
N 3,392 3,640 2,839 3,594 3,401 4,047 4,589 6,127 STEMI 42.0 46.0 54.0 47.0 53.0 50.8 52.0 50.0 NSTEMI 34.0 29.0 24.0 29.0 30.0 27.0 25.0 26.2
UA 24.0 24.0 22.0 24.0 17.0 22.2 23.3 23.8
Trang 17Type of cardiac presentation for patients with ACS (%)
by admission, NCVD-ACS Registry, 2006 - 2013
Trang 18Age group of patients by ACS stratum
NCVD-ACS Registry, 2011-2013
Trang 19Age group of patients by ACS stratum
NCVD-ACS Registry, 2011-2013
NSTEMI
Trang 22Type of treatment among STEMI patients by Age Group ,
NCVD-ACS Registry, 2011-2013
Trang 23Outcome at discharge 30-day FU Year Outcome N % N % 2006-2010 Alive 15531 92 14429 86
Trang 25Outcome at discharge 30-day FU
Physician Centre Cardiologist Centre Physician Centre Cardiologist Centre
2013 Alive Died 11238 934 92.4 7.6 2395 196 92.4 7.6 11064 1108 90.8 9.2 2376 215 91.8 8.2
30-day outcome is better at cardiologist centre
Trang 26STEMI: comparison between NCVD and
TIMI developmental dataset
An Asian Validation of the TIMI risk score for ST-Segment Elevation Myocardial Infarction: Results and
Implications for Cardiac Care in a Developing Country Sharmini Selvarajah, Alan Fong Yean Yip, Gunavathy Selvaraj, Jamaiyah Haniff, Cuno S.P.M Uiterwaal, Michiel L Bots, PLoS One 2012;7(7):e40249
Trang 27Guidelines (and patients) advocate
early intervention / invasive strategy! How?
Trang 28UK and Malaysia
Sarawak 2013 – Approx 280 PCI pmp
Trang 29STEMI reperfusion strategies in UK and Malaysia
Malaysia 2013 – approx 70% lytic, approx 9% PPCI
Trang 30More local research (….definitely needed!)
Trang 31Addressing the problems >3 billion at risk
Trang 32Regional collaboration – 2016 and beyond
Trang 33Malaysia CPGs for Acute STEMI
Trang 343 rd Malaysian CPG for STEMI
Trang 35Sharing our experience
Trang 36Thrombolysis in STEMI: developing countries
Trang 37A recent hit… with global implications
Trang 38Summary: how the NCVD has helped us…
Systematic collection of local data important
Better understanding of the local disease burden
Strategies to improve therapeutic protocols
Addressing the evidence gap by research
Translating research into guidelines
Trang 39Sarawak General Hospital
Disclaimer
Research/Educational Grants/Lecture Honoraria from Ministry of Health Malaysia, Astra Zeneca, Boehringer Ingelheim, B.Braun, Medtronic, Merck AG, MSD, Novartis AG, Orbus Neich, Pfizer Ltd, Roche Diagnositics, Siemens Diagnositics, Sanofi-Aventis St Jude Medical
Trang 40500km in October 2015 – World Heart Day
Trang 41Sarawak – more than just hornbills